Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR/HER2
Hamad M. Alkahtani, Ashraf N. Abdalla, Ahmad J. Obaidullah, et al.
Bioorganic Chemistry (2019) Vol. 95, pp. 103461-103461
Closed Access | Times Cited: 55

Showing 26-50 of 55 citing articles:

Design, synthesis, and carbonic anhydrase inhibition activities of Schiff bases incorporating benzenesulfonamide scaffold: Molecular docking application
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Silvia Bua, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 12, pp. 101866-101866
Open Access | Times Cited: 7
Exploring structure-activity relationship of S-substituted 2-mercaptoquinazolin-4(3H)-one including 4-ethylbenzenesulfonamides as human carbonic anhydrase inhibitors
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Hany E. A. Ahmed, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2020) Vol. 35, Iss. 1, pp. 598-609
Open Access | Times Cited: 18
Design, synthesis and biological evaluation of novel bischalcone derivatives as potential anticancer agents
Serdar Burmaoğlu, Arzu Gobek, Busra Ozturk Aydin, et al.
Bioorganic Chemistry (2021) Vol. 111, pp. 104882-104882
Closed Access | Times Cited: 16
The Antiproliferative and Apoptotic Effects of a Novel Quinazoline Carrying Substituted-Sulfonamides: In Vitro and Molecular Docking Study
Ali S. Alqahtani, Mostafa M. Ghorab, Fahd A. Nasr, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 981-981
Open Access | Times Cited: 11
Carbonic Anhydrase Inhibition Activities of Schiff’s Bases Based on Quinazoline-Linked Benzenesulfonamide
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Hazem A. Ghabbour, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7703-7703
Open Access | Times Cited: 11
Synthesis, antiproliferative and enzymatic inhibition activities of quinazolines incorporating benzenesulfonamide: Cell cycle analysis and molecular modeling study
Adel S. El‐Azab, Hamad M. Alkahtani, Nawaf A. Alsaif, et al.
Journal of Molecular Structure (2023) Vol. 1278, pp. 134928-134928
Closed Access | Times Cited: 6
Targeting of ErbB1, ErbB2, and their Dual Targeting Using Small Molecules and Natural Peptides: Blocking EGFR Cell Signaling Pathways in Cancer: A Mini-Review
M Chandrasekar, Sunil Kumar Patnaik, Nagarjuna Palathoti, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 22, Iss. 22, pp. 2831-2846
Closed Access | Times Cited: 9
Identification of potential therapeutic dual inhibitors of EGFR/HER2 in breast cancer
Megha Jethwa, Aditi Gangopadhyay, Achintya Saha
European Journal of Medicinal Chemistry Reports (2024) Vol. 11, pp. 100143-100143
Open Access | Times Cited: 1
Synthesis, enzyme inhibition assay, and molecular modeling study of novel pyrazolines linked to 4-methylsulfonylphenyl scaffold: antitumor activity and cell cycle analysis
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Simone Brogi, et al.
RSC Advances (2024) Vol. 14, Iss. 31, pp. 22132-22146
Open Access | Times Cited: 1
Molecular docking analysis of HER-2 inhibitor from the ZINC database as anticancer agents
Khalid Sait
Bioinformation (2020) Vol. 16, Iss. 11, pp. 882-882
Open Access | Times Cited: 13
Design, synthesis and anticancer evaluation of new 4-anilinoquinoline-3-carbonitrile derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers
Min Zou, Jiawen Li, Bo Jin, et al.
Bioorganic Chemistry (2021) Vol. 114, pp. 105200-105200
Closed Access | Times Cited: 12
Novel Microcrystal Formulations of Sorafenib Facilitate a Long-Acting Antitumor Effect and Relieve Treatment Side Effects as Observed With Fundus Microcirculation Imaging
Junxiao Wang, Rui Liu, Yun Zhao, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 12
New pyrimidine-5-carbonitrile derivatives as EGFR inhibitors with anticancer and apoptotic activities: design, molecular modeling and synthesis
Ibrahim A. Osman, Rezk R. Ayyad, Hazem A. Mahdy
New Journal of Chemistry (2022) Vol. 46, Iss. 24, pp. 11812-11827
Closed Access | Times Cited: 8
Novel 2-Sulfanylquinazolin-4(3H)-one Derivatives as Multi-Kinase Inhibitors and Apoptosis Inducers: A Synthesis, Biological Evaluation, and Molecular Docking Study
Ali Altharawi, Mohammed M. Alanazi, Manal A. Alossaimi, et al.
Molecules (2023) Vol. 28, Iss. 14, pp. 5548-5548
Open Access | Times Cited: 4
Synthesis, cytotoxicity and apoptosis‐inducing activity of novel 1H‐benzo[d]imidazole derivatives of dehydroabietic acid
A‐Liang Li, Ya‐Qun Yang, Wenyan Wang, et al.
Journal of the Chinese Chemical Society (2020) Vol. 67, Iss. 9, pp. 1668-1678
Closed Access | Times Cited: 8
Design, synthesis, and analysis of antiproliferative and apoptosis-inducing activities of nitrile derivatives containing a benzofuran scaffold: EGFR inhibition assay and molecular modelling study
Salma Fares, Khalid B. Selim, Fatma E. Goda, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1487-1498
Open Access | Times Cited: 7
Synthesis, Cytotoxic Evaluation, and Structure-Activity Relationship of Substituted Quinazolinones as Cyclin-Dependent Kinase 9 Inhibitors
Hamad M. Alkahtani, Amer Alhaj Zen, Ahmad J. Obaidullah, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 120-120
Open Access | Times Cited: 5
Green synthesis of 2‐thioxo‐4‐quinazolinones from 2‐aminobenzamide and isothiocyanates
Ngoc Binh Vo, Le Thanh Hang Nguyen, Thi Yen Tran, et al.
Vietnam Journal of Chemistry (2024) Vol. 62, Iss. S1, pp. 147-152
Open Access
Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment
Meduri Bhagyalalitha, Akshatha Handattu Shankaranarayana, Sethu Arun Kumar, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107695-107695
Closed Access
Synthesis and Biological Evaluation of Novel Furopyridone Derivatives as Potent Cytotoxic Agents against Esophageal Cancer
Xingyu Ren, Jiaojiao Zhang, Anying Dai, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9634-9634
Open Access
Synthesis and Evaluation of Thiazolyl-indole-2-carboxamide Derivatives as Potent Multitarget Anticancer Agents
Njood M. Saadan, Wahid U. Ahmed, Adnan A. Kadi, et al.
ACS Omega (2024) Vol. 9, Iss. 40, pp. 41944-41967
Open Access
Phytotherapeutic potential of Campomanesia xanthocarpa (Mart.) O. Berg: antitumor effects in vitro and in silico, with emphasis on SK-MEL-28 melanoma cells—a study on leaf and fruit infusions
Vanessa Ruana Ferreira da Silva, Gilnei Bruno da Silva, Daiane Manica, et al.
In Silico Pharmacology (2024) Vol. 12, Iss. 2
Closed Access
Design, Synthesis, Computational Studies and Evaluation of Novel 2, 4, 5-Trisubstituted Pyrimidine Derivatives for Anticancer Activity against MCF-7 and A549 Cell Lines
Chintan Sheth, Pinkal Patel, Umang Shah
Journal of Molecular Structure (2024), pp. 140987-140987
Closed Access
Antitumor Activity and Multi-Target Mechanism of Phenolic Schiff Bases Bearing Methanesulfonamide Fragments: Cell Cycle Analysis and a Molecular Modeling Study
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Simone Brogi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13621-13621
Open Access
Privileged Scaffolds in Drug Discovery against Human Epidermal Growth Factor Receptor 2 for Cancer Treatment
Mudasir Nabi Peerzada, Rania Hamdy, Masood Ahmad Rizvi, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 44, pp. 3563-3578
Closed Access | Times Cited: 1

Scroll to top